{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-241556","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2025-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.065238+00:00","generated_at":"2026-05-17T03:34:11.805586+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Iterum files $20M ATM offering; ORLYNVAH launched Aug 2025 with modest sales expected","bullets":["Filed prospectus supplement for ATM offering of up to $20M aggregate gross proceeds (max ~21.8M ordinary shares).","Previously raised approximately $36.2M under same Sales Agreement with H.C. Wainwright.","ORLYNVAH commercially launched in U.S. in August 2025; company expects modest sales in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-241556","json":"https://secwatch.observer/filing/0001193125-25-241556.json","markdown":"https://secwatch.observer/filing/0001193125-25-241556.md","text":"https://secwatch.observer/filing/0001193125-25-241556.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000119312525241556/0001193125-25-241556-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000119312525241556/d933718d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:34:11.805586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}